Veralox Therapeutics

Veralox is a clinical stage company developing first-in-class small molecule therapeutics that treat the underlying pathologies of immuno-inflammatory diseases heparin-induced thrombocytopenia (HIT) and type 1 diabetes (T1D), as well as several programs in the discovery phase.

Veralox Therapeutics

Frederick, MD


Veralox Secures $24MM Financing to Advance Development of First-i…

Read More